FIRECREST
LIVE

Serial Number

79105963

Owner

ICON Clinical Research Limited

Attorney

Rebecca E. McDougall

Filing Date

Aug 24, 2010

Add to watchlist:

No watchlists yet
View on USPTO

FIRECREST Trademark

Serial Number: 79105963 • Registration: 4329839

FIRECREST is a trademark filed by ICON Clinical Research Limited on August 24, 2010. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

ICON Clinical Research Limited (8 trademarks)

South County Business Park, Leopardstown
Dublin 18 , IE

Entity Type: 03

FIRECREST CLINICAL LIMITED

Unit 1, Mary Rosse Centre, Holland Road,

Entity Type: 99

Trademark Details

Filing Date

August 24, 2010

Registration Date

May 7, 2013

Published for Opposition

February 19, 2013

Goods & Services

Educational services, namely, providing web-based training in the field of clinical studies, clinical data, clinical research, clinical treatment, support and guidance in medicine and surgery, in the pharmaceutical, biotechnology and medical device fields; educational services, namely, training in the field of clinical research and analysis and in the fields of chemicals and pharmaceuticals and the use of information technology in relation to clinical research, analysis, chemicals and pharmaceuticals; [ educational services, namely, conducting and organizing seminars, conferences, symposiums, colloquium and discussion groups in relation to clinical research, analysis, chemicals and pharmaceuticals; ] online and electronic publication of [ scientific papers, ] documents and reports pertinent to a particular study all in connection with clinical studies, clinical data and clinical research in relation to pharmaceuticals and clinical trials in the pharmaceutical, biotechnology and medical device fields

[ Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signaling, checking supervision and teaching apparatus and instruments, namely, printers; apparatus for recording, transmission or reproduction of sound or images; data processing equipment and computers; computer software for use in website development and management, creation and compilation of spreadsheets, analysis of data, maintenance, distribution and dissemination of data in the field of scientific research, namely, clinical research, clinical studies, clinical trials and clinical treatment, support and guidance in medicine and surgery in the pharmaceutical, biotechnology and medical device fields, including site information and laboratory analysis in the field of pharmaceuticals, biotechnology and medical devices; computer hardware and peripheral devices; computers; laptop computers; tablet computers; computer screens; computer firmware for use in the development, analysis and management of databases in the field of scientific research, namely, clinical research, clinical studies, clinical trials and clinical treatment, support and guidance in medicine and surgery in the pharmaceutical, biotechnology and medical device fields; downloadable electronic publications in the nature of [ scientific papers, ] documents, and reports pertinent to clinical studies, clinical data, clinical research, clinical treatment, support and guidance in medicine and surgery in relation to pharmaceuticals and clinical trials in the fields of pharmaceuticals, biotechnology and medical devices; computer programs for use in preparation of data results, analysis of results, development and delivery of training programs relating to clinical research and analysis; Computer software for use in collating, analyzing data and reporting findings and site management in the fields of chemicals, pharmaceuticals and clinical trials; pre-recorded magnetic data carriers featuring information and data in the field of scientific research, namely, clinical research, clinical studies, clinical trials and clinical treatment, support and guidance in medicine and surgery in the pharmaceutical, biotechnology and medical device fields ]

[ Scientific research; Scientific and technological services, namely, research and design and laboratory analysis in the field of pharmaceuticals and clinical trials in the pharmaceutical, biotechnology and medical device fields; Industrial research services in the field of pharmaceuticals and clinical trials in the pharmaceutical, biotechnology and medical device fields; ] Design and development of [ computer hardware and ] software

Filing History

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Sep 11, 2024 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 5, 2024 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jan 4, 2024 NA71
REGISTERED-SEC.71 ACCEPTED
Jan 4, 2024 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 3, 2024 APRE
TEAS SECTION 71 RECEIVED
May 5, 2023 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
May 7, 2022 REM4
PARTIAL INVALIDATION PROCESSED BY THE IB
Oct 24, 2021 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 7, 2021 INPS
INVALIDATION PROCESSED
Sep 7, 2021 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 29, 2021 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Dec 29, 2020 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Dec 29, 2020 C75P
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Dec 16, 2020 EROP
INTERNATIONAL REGISTRATION RENEWED
Oct 1, 2020 RNWL
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Jun 16, 2020 PR75
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Apr 9, 2020 EROP
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Oct 9, 2019 PR75
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 9, 2019 APRE
TEAS SECTION 71 & 15 RECEIVED
Oct 6, 2019 ES75
NEW REPRESENTATIVE AT IB RECEIVED
Sep 5, 2019 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 7, 2018 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Nov 24, 2016 NREP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 2, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 2, 2016 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 30, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 14, 2013 FICS
FINAL DISPOSITION PROCESSED
Aug 14, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 7, 2013 FICR
REGISTERED-PRINCIPAL REGISTER
May 7, 2013 R.PR
NOTIFICATION PROCESSED BY IB
Mar 10, 2013 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 19, 2013 NPUB
PUBLISHED FOR OPPOSITION
Feb 19, 2013 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 30, 2013 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 30, 2013 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 30, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 14, 2013 PREV
ASSIGNED TO LIE
Jan 10, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 21, 2012 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 21, 2012 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 21, 2012 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 21, 2012 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 21, 2012 CNEA
EXAMINER'S AMENDMENT ENTERED
Dec 21, 2012 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 21, 2012 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 21, 2012 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 21, 2012 CNEA
CHANGE OF OWNER RECEIVED FROM IB
Dec 21, 2012 CHLD
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 23, 2012 GNFN
FINAL REFUSAL E-MAILED
Jun 23, 2012 GNFR
FINAL REFUSAL WRITTEN
Jun 23, 2012 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 22, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 21, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 21, 2012 TROA
REFUSAL PROCESSED BY IB
Jan 9, 2012 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 21, 2011 RFCS
REFUSAL PROCESSED BY MPU
Dec 21, 2011 RFRR
APPLICATION FILING RECEIPT MAILED
Dec 20, 2011 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 18, 2011 RFCR
NON-FINAL ACTION WRITTEN
Dec 17, 2011 CNRT
ASSIGNED TO EXAMINER
Dec 16, 2011 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 16, 2011 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 15, 2011 REPR